Back to MW MARSHALL WACE, LLP

AMGNAMGN
Showing 7 of 28 quarters

Position history for MWMARSHALL WACE, LLP's holdings in AMGEN INC

MARSHALL WACE, LLP holds 99,402 shares of AMGN (AMGEN INC), worth $36M as of 2026-Q2. The position was decreased (-68.6% shares). AMGN represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$36M

Current Shares

99,402

Total Value Change

-$191.2M

Total Shares Change

-605,709

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
99,402
-68.6%
$36M0.0%$362.12
0
2026-Q1
Increased
316,917
+220.6%
$111.5M0.1%$349.21
58
2025-Q4
New
98,852
-
$32.4M0.0%$322.62
40
2025-Q2
Exited
0
-100.0%
$00.0%$271.06
0
2025-Q1
Increased
178,257
+2836.2%
$55.5M0.1%$299.81
47
2024-Q4
Decreased
6,071
-99.1%
$1.6M0.0%$248.81
0
2024-Q3
Increased
705,111
+7.4%
$227.2M0.3%$305.14
39

Other major holders of AMGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock, Inc., Steward Partners Investment Advisory, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used